Latest renal dialysis Stories
The goal of GranuFlolawsuit.net is to educate dialysis patients and their families who have experienced sudden cardiac arrest and other serious side effects while undergoing dialysis with GranuFlo between November 2011 and March 2012. Those injured may be eligible to pursue a GranuFlo lawsuit. San Diego, CA (PRWEB) August 08, 2012 The dangerous product lawyers at Estey & Bomberger, LLP recently launched a new GranuFlo lawsuit information website (http://granuflolawsuit.net) for...
ORLANDO, Fla., Aug. 7, 2012 /PRNewswire/ -- Information Architects Corporation (OTCQB: IACH) announced today on Monday, August 6th, the company signed a contract to acquire The Miami Prevention & Kidney Center LLC. (MPKC). Founded in 2008, the centers will provide lifesaving hemodialysis to individuals diagnosed with End Stage Renal Disease (ESRD). The initial center is scheduled to begin providing dialysis services for patients in the South Florida area beginning by the end of...
Dialysis products recalled – Risk of Heart Attack and Sudden Death. Philadelphia, PA (PRWEB) July 26, 2012 Levin, Fishbein, Sedran & Berman, a prominent national plaintiff law firm, alerts patients that on June 27, 2012, the FDA issued a Class-1 recall for Fresenius Medical Care North America's dialysis products, Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate, due to a risk of potentially fatal serum bicarbonate levels. Naturalyte Liquid and...
Longest placebo-controlled trial of phosphate binders conducted to date challenges the drugs' utility Highlights: -Phosphate binders, drugs commonly prescribed to patients with chronic kidney disease, may not be as effective as previously thought. -Phosphate binders may have negative effects on cardiovascular health. -Additional studies are needed on the safety and effectiveness of these drugs. Drugs commonly prescribed to patients with chronic kidney disease (CKD) may not be as...
Ennis & Ennis, P.A. Announces Free Nationwide Consultations for Patients Affected by Fresenius' Naturalyte and GranuFlo Recall (PRWEB) July 18, 2012 On June 27, 2012, the FDA issued a recall for Fresenius Medical Care North America's dialysis products, Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate, due to a risk of potentially fatal serum bicarbonate levels. Naturalyte Liquid and Naturalyte GranuFlo are dialysis products. On November...
Parker Waichman is now advising that the FDA has issued a Class I Recall for GranuFlo and NaturaLyte Dialysis Products manufactured by Fresenius Medical Care. This FDA Action Follows Revelation that Over 900 Patients Suffered Cardiac Arrest at Fresenius Dialysis Clinics in 2010. According to the company, GranuFlo and NaturaLyte are Associated with Elevated Bicarbonate Levels, a Significant Risk Factor for Cardiac Arrest. New York, New York (PRWEB) June 28, 2012 Parker Waichman LLP, a...
The national law firm of Parker Waichman LLP is alerting the public to an internal memo by Fresenius Medical Care, which states that over 900 patients within their clinics suffered from cardiac arrest in 2010 alone. The memorandum also emphasizes elevated bicarbonate levels as a significant risk factor for such events, an issue that is linked to the dialysis products GranuFlo and NaturaLyte. (PRWEB) June 21, 2012 Parker Waichman LLP, a national law firm dedicated to protecting victims...
(Ivanhoe Newswire) – An estimated 26 million American adults suffer with chronic kidney disease (CKD), and according to a new study, many cases are left untreated, especially among the elderly. In the study that included nearly two million adults in Canada, the rate of progression to untreated kidney failure was considerably higher among older adults (85 years and older), compared to younger individuals. Past research had indicated that older adults were least likely to have untreated...
NEW YORK, June 6, 2012 /PRNewswire/ -- Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, today announced that Rob Chioini, CEO, and Ajay Gupta, M.D., CSO (Chief Scientific Officer) will co-present at RetailInvestorConferences.com. DATE: June 7, 2012TIME:...
LONG BEACH, Calif., June 6, 2012 /PRNewswire/ -- Innovative Dialysis Systems announced today that Anita Lipman, BSN, MS, CNN, has accepted the newly-created position of National Director, Home Dialysis. "We are very pleased that Ms. Lipman has joined our team," said Larry Jones, President and Chief Operating Officer of Innovative Dialysis. "We created the position of National Director, Home Dialysis to help us reinvigorate our focus on home dialysis therapies in the markets that...
